POLYPROXIN

Welcome to the Brand page for “POLYPROXIN”, which is offered here for Pharmaceuticals, drugs and pharmaceutical preparations for the treatment of cancers, neurological diseases, metabolic diseases, cardiovascular diseases, autoimmune and inflammatory diseases; pharmaceuticals, drugs and pharmaceutical preparations for the treatment of cancer, including lung, colorectal and pancreatic cancers;chemicals, chemical compounds and biologic compounds for use in industry and science; chemicals, chemical compounds and biologic compounds for use in industry and science, other than for medical or veterinary use; chemicals, chemical compounds and biologic compounds for scientific, laboratory or research purposes, in particular for use in the manufacture of pharmaceuticals and drugs for the treatment of cancer, including lung, colorectal and pancreatic cancers;medical services; medical services connected with the treatment of cancer, including lung, colorectal and pancreatic cancers;scientific and technological services, scientific research, analysis, design and testing in the field of pharmaceuticals, drugs and pharmaceutical preparations; drug discovery and drug development services; conducting or providing research and development services for others in the field of pharmaceuticals, drugs and pharmaceutical preparations for the treatment of cancer, including lung, colorectal and pancreatic cancers;.

Its status is currently believed to be active. Its class is unavailable. “POLYPROXIN” is believed to be currently owned by “PolyProx Therapeutics Ltd”.